Plexus Corp. (PLXS) Stock Price & How to Invest

Last updated July 2026

Short answer

PLXS is Plexus Corp, a specialty electronics manufacturing services (EMS) company that designs and builds highly complex, regulated products in aerospace/defense, healthcare, and industrial markets. It is a profitable, niche EMS operator that has re-rated sharply higher, so the investment question is less about the business quality and more about whether the current premium valuation is justified.

PLXS stock price

As of 2026-07-14, Plexus Corp. (PLXS) last closed at $260.36, up 93.5% over the past year. Over the past 52 weeks it has traded between $118.29 and $303.82.

PLXS last close
$260.36
1 day
+0.51%
1 month
-11.75%
1 year
+93.50%
52-week range
$118.29 to $303.82
Last close
2026-07-14

Prices are daily closing prices from Yahoo Finance and may be delayed. For the live quote, check your broker or Plexus Corp.'s investor relations page. Walnut is informational, not investment advice.

What does Plexus Corp. (PLXS) do?

Plexus Corp (NASDAQ: PLXS), headquartered in Neenah, Wisconsin and operating since 1979, is a contract electronics manufacturer that provides integrated lifecycle solutions spanning design and development, supply chain, new product introduction, manufacturing, and aftermarket services. Unlike the scale-driven giants of the EMS industry, Plexus deliberately targets mid-to-low volume, higher-complexity programs in three regulated sectors: Aerospace/Defense, Healthcare/Life Sciences, and Industrial. Its work includes life-saving medical devices, mission-critical defense electronics, industrial automation, and semiconductor capital equipment, where certifications, traceability, and engineering rigor matter more than raw volume economics.

The investment picture is one of a high-quality niche operator that the market has recently embraced. Fiscal 2026 has featured record revenue and expanding margins, with the stock roughly doubling over twelve months as investors reassessed the structural role EMS players hold in modern supply chains. That enthusiasm has pushed the valuation to a premium relative to Plexus's own history. Bulls point to durable demand in defense and medical and to margin discipline, while skeptics note that the multiple has expanded faster than earnings and that Plexus's exposure to the AI infrastructure theme is indirect.

What's driving Plexus Corp. (PLXS)?

1. Regulated-market specialization

Plexus concentrates on aerospace/defense, healthcare/life sciences, and industrial customers where strict regulatory and quality requirements create high switching costs. This focus tends to support steadier margins and stickier programs than commodity high-volume manufacturing. It also gives Plexus pricing leverage that pure scale players struggle to match.

2. Program ramps and revenue momentum

Recent quarters have shown strong year-over-year revenue growth driven by ramping programs across all three sectors, including industrial semiconductor capital equipment and defense. Fiscal Q2 2026 delivered record revenue of roughly $1.16 billion, up around 19% year over year. Continued program wins and ramps are the primary near-term growth driver.

3. Margin expansion and mix

Management has emphasized improving operating margins as higher-complexity, higher-value work grows as a share of the mix. Non-GAAP operating margin reached about 6.0% in fiscal Q2 2026. Sustained mix improvement toward premium programs is central to the earnings-growth story.

4. Supply-chain and reshoring tailwinds

Structural interest in resilient, diversified, and regionalized manufacturing supply chains has increased demand for capable EMS partners. Plexus's global footprint across the Americas, EMEA, and Asia-Pacific positions it to serve customers seeking flexibility. Broader AI-infrastructure and industrial-electronics spending indirectly supports order flow.

What are the risks to Plexus Corp. (PLXS)?

The most cited risk is valuation: the stock has roughly doubled in a year and trades at a premium price-to-earnings multiple, creating meaningful downside if growth or margins disappoint. EMS is cyclical and demand can soften quickly if end-market customers cut orders or push out programs. Plexus depends on a relatively concentrated set of large customers, so the loss or slowdown of a major program can materially affect results. Tariffs, trade disputes, and shifting trade policy add cost and complexity to a globally distributed manufacturing base. Finally, Plexus's AI exposure is indirect, which could limit upside relative to peers with more direct data-center content while still leaving it exposed to any broad tech-spending pullback.

How is Plexus Corp. (PLXS) valued? (approximate, July 2026)

A simple financial snapshot. These are approximations and refresh quarterly; for current figures see Plexus Corp.'s investor relations page or your broker.

  • Revenue (TTM): ~$4.1B
  • Net income (TTM): ~$173M
  • Fiscal Q2 2026 revenue: ~$1.16B (record)
  • Fiscal Q2 2026 non-GAAP EPS: ~$2.05
  • Market cap: ~$7B
  • P/E (TTM): ~34x to 38x

Plexus generates roughly $4.1 billion in trailing revenue and around $173 million in net income, with fiscal Q2 2026 setting a quarterly revenue record near $1.16 billion. The stock has roughly doubled over the prior year, lifting its trailing P/E into the mid-to-high 30s and its forward P/E to the high 20s to low 30s. That places it at a premium to its own history and richer than several EMS peers, reflecting optimism about margin expansion that has already been partly priced in.

Who competes with Plexus Corp. (PLXS)?

Large-scale EMS giants

Jabil and Flex operate at roughly $25 billion or more in annual revenue, dwarfing Plexus on scale and serving high-volume markets. They compete on cost and breadth, whereas Plexus competes on complexity and regulatory expertise rather than volume economics.

Complexity-focused EMS peers

Celestica, Sanmina, and Benchmark Electronics overlap most directly with Plexus in higher-mix, higher-complexity programs across aerospace/defense, medical, and industrial customers. Celestica in particular has drawn attention for AI data-center exposure, a comparison frequently drawn against Plexus's more indirect exposure.

In-house manufacturing

Some OEM customers can manufacture products themselves rather than outsource to an EMS partner. The threat of insourcing, especially for lower-complexity work, is a structural competitive factor, though Plexus's regulated-market specialization makes its programs harder to bring in-house.

How to invest in Plexus Corp. (PLXS)

There are three common ways to get PLXS exposure. Buy shares (or fractional shares) directly at any major broker. Hold an ETF that includes it, which spreads the position across many companies. Or build it into a focused thematic basket, so PLXS sits alongside other stocks that express the same thesis.

Walnut takes the basket route. Describe a thesis where PLXS fits (for example “AI infrastructure” or “dividend-growth large-caps”) and the AI proposes 5 to 6 constituents with target weights. You review the plan and fund it through your own broker when you're ready.

The bottom line on Plexus Corp. (PLXS)

Plexus is a well-run, complexity-focused EMS partner whose fundamentals are solid, but the stock has run hard and now trades at a rich multiple that leaves little room for disappointment.

More on Plexus Corp. (PLXS)

Whether PLXS is worth buying today depends more on your time horizon and what you already hold than on any single call. We walk through valuation, what would have to go right, and the risks in is PLXS a buy?, and where the stock could go from here in the PLXS stock forecast.

For income investors, whether PLXS pays a dividend and how the payout looks is covered in does PLXS pay a dividend?

Build a basket around PLXS with Walnut

Use Plexus Corp. as one constituent in a thematic basket Walnut's AI helps you assemble. Describe a thesis you believe in, the AI proposes the holdings and weights, and you approve before any broker order.

FAQ

What does Plexus Corp do?

+

Plexus is an electronics manufacturing services (EMS) company. It designs, manufactures, and services highly complex electronic products for customers in aerospace/defense, healthcare/life sciences, and industrial markets, handling everything from design and supply chain to manufacturing and aftermarket support.

What makes Plexus different from Jabil or Flex?

+

Jabil and Flex are far larger and focus on high-volume manufacturing, each generating well over $25 billion in revenue. Plexus is much smaller at around $4 billion and specializes in mid-to-low volume, high-complexity programs in regulated industries where certifications and traceability matter more than scale.

Is Plexus profitable?

+

Yes. Plexus is consistently profitable, with trailing twelve-month net income of roughly $173 million on about $4.1 billion of revenue. Fiscal Q2 2026 delivered record revenue and a non-GAAP operating margin near 6.0%.

Why has PLXS stock risen so much?

+

The stock roughly doubled over the past year as investors re-rated EMS companies for their structural role in supply chains, and as Plexus posted record revenue and margin expansion. The enthusiasm has pushed its valuation to a premium relative to its own history.

What are the main risks with PLXS?

+

The largest concern is valuation after a strong run, which raises the risk of multiple compression if results disappoint. Other risks include the cyclicality of EMS demand, concentration among large customers, tariff and trade-policy exposure, and only indirect exposure to the AI-infrastructure theme.

Does Plexus benefit from AI data-center demand?

+

Its exposure is indirect. Plexus serves industrial, semiconductor capital equipment, and other markets that touch AI infrastructure supply chains, but it does not have the same direct data-center content as some peers, which some analysts view as a limit on upside.

How large is Plexus?

+

Plexus has a market capitalization of roughly $7 billion as of mid-2026, with about $4.1 billion in trailing revenue. It is a mid-cap company and one of the smaller publicly traded EMS providers relative to giants like Jabil and Flex.

How does PLXS fit into a portfolio or basket?

+

PLXS is typically viewed as a mid-cap industrial or technology-hardware holding tied to electronics manufacturing, defense, medical devices, and industrial capital equipment. How it fits any specific strategy depends on your own goals and risk tolerance. Walnut is not an investment adviser.

Walnut is informational, not investment advice. Financial figures on this page are approximations; always verify current numbers with Plexus Corp.'s investor relations page or your broker before making investment decisions.